Sun Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SUN PHARM
SUN PHARM has seven hundred and three approved drugs.
There are fifty-nine US patents protecting SUN PHARM drugs. There are twenty tentative approvals on SUN PHARM drugs.
There are four hundred and seventy-six patent family members on SUN PHARM drugs in fifty-nine countries and seven hundred and thirty supplementary protection certificates in twenty countries.
Summary for Sun Pharm
| International Patents: | 476 |
| US Patents: | 59 |
| Tradenames: | 425 |
| Ingredients: | 387 |
| NDAs: | 703 |
| Patent Litigation for Sun Pharm: | See patent lawsuits for Sun Pharm |
| PTAB Cases with Sun Pharm as petitioner: | See PTAB cases with Sun Pharm as petitioner |
Drugs and US Patents for Sun Pharm
Expired US Patents for Sun Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Inc | LAC-HYDRIN | ammonium lactate | LOTION;TOPICAL | 019155-001 | Apr 24, 1985 | 4,105,783 | ⤷ Start Trial |
| Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-002 | May 25, 2012 | 9,089,534 | ⤷ Start Trial |
| Sun Pharma Canada | TOPICORT | desoximetasone | SPRAY;TOPICAL | 204141-001 | Apr 11, 2013 | 5,990,100 | ⤷ Start Trial |
| Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-003 | May 25, 2012 | 7,435,427 | ⤷ Start Trial |
| Sun Pharm Inds Inc | ULTRAVATE | halobetasol propionate | CREAM;TOPICAL | 019967-001 | Dec 27, 1990 | 4,619,921 | ⤷ Start Trial |
| Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-003 | May 25, 2012 | 8,952,064 | ⤷ Start Trial |
| Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-002 | May 25, 2012 | 8,367,102 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SUN PHARM drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Topical Spray | 0.25% | ➤ Subscribe | 2013-12-18 |
| ➤ Subscribe | Capsules | 20 mg | ➤ Subscribe | 2013-06-19 |
| ➤ Subscribe | Capsules | 30 mg and 40 mg | ➤ Subscribe | 2012-12-31 |
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
| ➤ Subscribe | Tablets | 125 mg | ➤ Subscribe | 2018-07-23 |
| ➤ Subscribe | Capsules | 20 mg | ➤ Subscribe | 2013-01-07 |
| ➤ Subscribe | Capsules | 25 mg | ➤ Subscribe | 2016-05-16 |
| ➤ Subscribe | Capsules | 35 mg | ➤ Subscribe | 2015-11-25 |
International Patents for Sun Pharm Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2026203479 | ⤷ Start Trial |
| Japan | 2019514873 | ⤷ Start Trial |
| Colombia | 2017002472 | ⤷ Start Trial |
| Poland | 2503004 | ⤷ Start Trial |
| Portugal | 3452039 | ⤷ Start Trial |
| Australia | 2021107564 | ⤷ Start Trial |
| Norway | 2025055 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Sun Pharm Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1534313 | 122015000111 | Germany | ⤷ Start Trial | PRODUCT NAME: PHENYLEPHRIN UND KETOROLAC; REGISTRATION NO/DATE: EU/1/15/1018 20150728 |
| 1586316 | 2011C/027 | Belgium | ⤷ Start Trial | PRODUCT NAME: BROMFENAC; AUTHORISATION NUMBER AND DATE: EU/1/11/692/001 20110523 |
| 0565634 | 06C0030 | France | ⤷ Start Trial | PRODUCT NAME: EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 32075 20060623; FIRST REGISTRATION: LI - 55783 01 20020607 |
| 1506211 | C01506211/02 | Switzerland | ⤷ Start Trial | PRODUCT NAME: DAPAGLIFLOZIN + METFORMIN; REGISTRATION NO/DATE: SWISSMEDIC 65377 16.07.2015 |
| 0817775 | SPC/GB06/008 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: ERLOTINIB OR A PHARMACEUTICALLY ACCEPTABLE SALT OR POLYMORPH THEREOF, IN PARTICULAR THE HYDROCHLORIDE SALT; REGISTERED: CH 5726601 20050321; CH 5726602 20050321; CH 5726603 20050321; UK EU/1/05/311/001 20050919; UK EU/1/05/311/002 20050919; UK EU/1/05/311/003 20050919 |
| 1304992 | 1390049-3 | Sweden | ⤷ Start Trial | PRODUCT NAME: KLINDAMYCIN (SOM KLINDAMYCINFOSFAT) OCH TRETINOIN; NAT. REG. NO/DATE: MTNR 46193 20130503; FIRST REG.: IR PA1332/043/001 20130322 |
| 1280520 | C300722 | Netherlands | ⤷ Start Trial | PRODUCT NAME: TOBRAMYCINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: C(2011)5394 20110720 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.

